Eugia Pharma Specialities Limited Lenalidomide Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Lenalidomide Export Records India — #2 Exporter, 189 Shipments, $9.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Eugia Pharma Specialities Limited — Lenalidomide Exporter #2 | $9.4M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Lenalidomide Exporter Profile

Indian Pharmaceutical Exporter · #2 for Lenalidomide · $9.4M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #2 Indian exporter of Lenalidomide with $9.4M in export value and 189 verified shipments. Eugia Pharma Specialities Limited holds a 1.1% market share in Lenalidomide exports across 3 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Lenalidomide Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Lenalidomide export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Lenalidomide?

Country	Value	Shipments	Share
UNITED STATES	$2.4M	48	63.4%
MALTA	$1.0M	134	27.3%
UNITED STATES OF AMERICA	$200.0K	4	5.3%
LEBANON	$150.0K	3	4.0%

Who Are the Top Buyers of Lenalidomide from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
AUROBINDO PHARMA USA., INC,	UNITED STATES	$1.9M	38
AUROBINDO PHARMA USA INC	UNITED STATES OF AMERICA	$650.0K	13
EUGIA PHARMA MALTA LTD	MALTA	$317.8K	29
EUGIA PHARMA (MALTA) LTD	MALTA	$246.5K	41
EUGIA PHARMA (MALTA) LTD,	MALTA	$236.9K	25
INTER PHARMA S.A.L,,	LEBANON	$150.0K	3
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$118.0K	16
EUGIA PHARMA (MALTA) LIMITED	MALTA	$68.8K	13
AUROBINDO PHARMA USA., INC	UNITED STATES	$50.0K	1
APL SWIFT SERVICES (MALTA) LTD	MALTA	$24.5K	2

Eugia Pharma Specialities Limited supplies Lenalidomide to 12 buyers globally. The largest buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by AUROBINDO PHARMA USA INC (UNITED STATES OF AMERICA) and EUGIA PHARMA MALTA LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Lenalidomide Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
LENALIDOMIDE CAPSULES 10 MG (LENALIDOMIDE CAPSULES 10 MG US (HDPE 28 S COUNT)) (QTY: 720 PACKS)	$150.0K	3
LENALIDOMIDE CAPSULES 10MG (LENALIDOMIDECAPSULES 10 MG US (HDPE 28 S COUNT)) (QTY: 816 PACKS)	$150.0K	3
LENALIDOMIDE CAPSULES 25 MG(LENALIDOMIDECAPSULES 25 MG AE US(HDPE 21 S COUNT))(QTY: 144 PACK 3024 EACH)	$100.0K	2
LENALIDOMIDE CAPSULES 25 MG Lenalidomide 25 mg Capsules - 3x7's Blister Puren Germany 3002 Packs	$86.3K	2
LENALIDOMIDE CAPSULES 15 MG Lenalidomide 15 mg Capsules - 3x7's Blister Puren Germany 3217 Packs	$58.3K	2
LENALIDOMIDE CAPSULES 25MG(LENALIDOMIDE	$53.7K	2
LENALIDOMIDE CAPSULES 10 MG Lenalidomide 10 mg Capsules Spain 7277 Packs	$50.0K	1
LENALIDOMIDE CAPSULES 20 MG (LENALIDOMIDE CAPSULES 20MG US (HDPE 21S COUNT)) (QTY: 156 PACKS)	$50.0K	1
LENALIDOMIDE CAPSULES 2.5 MG (LENALIDOMIDE CAPSULES 2.5MG US (HDPE 28S COUNT)) (QTY: 127 PACKS)	$50.0K	1
LENALIDOMIDE CAPSULES 5 MG (LENALIDOMIDECAPSULES 5MG US (HDPE 28S COUNT)) (QTY:552 PACKS)	$50.0K	1

Eugia Pharma Specialities Limited exports 151 distinct Lenalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LENALIDOMIDE CAPSULES 10 MG (LENALIDOMIDE CAPSULES 10 MG US with 3 shipments worth $150.0K.

How Does Eugia Pharma Specialities Limited Compare to Nearest Lenalidomide Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	EUGIA PHARMA SPECIALITIES LIMITED ★	$9.4M	189	3	$50.0K
5	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$8.3M	281	16	$29.4K
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$7.2M	144	6	$50.0K

Eugia Pharma Specialities Limited ranks #2 among 237 Indian Lenalidomide exporters. Average shipment value of $50.0K compared to the market average of $128.1K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Lenalidomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	740	27.2%
SAHAR AIR	688	25.3%
DELHI AIR CARGO ACC (INDEL4)	187	6.9%
Bombay Air	180	6.6%
DELHI AIR	140	5.1%
Bombay Air Cargo	88	3.2%
HYDERABAD ACC (INHYD4)	78	2.9%
HYDERABAD AIR	68	2.5%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Lenalidomide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lenalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 189 individual customs records matching Eugia Pharma Specialities Limited exporting Lenalidomide, covering 151 formulations to 4 countries via 12 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 557+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lenalidomide

Lenalidomide

Eugia Pharma Specialities Limited — Lenalidomide Exporter Profile

Eugia Pharma Specialities Limited — Lenalidomide Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Lenalidomide?

Who Are the Top Buyers of Lenalidomide from Eugia Pharma Specialities Limited?

What Is India's Total Lenalidomide Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Lenalidomide Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Lenalidomide Exporters?

What Lenalidomide Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Lenalidomide to Key Markets

United States — FDA

How Does Eugia Pharma Specialities Limited Compare to Nearest Lenalidomide Exporters?

Which Indian Ports Ship Lenalidomide Exports?

What Other Advanced Oncology Products Does Eugia Pharma Specialities Limited Export?

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Lenalidomide Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lenalidomide Export Data from Eugia Pharma Specialities Limited

Lenalidomide Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source